KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $2.7 million.

  • Staar Surgical's Cash from Operations fell 3011.01% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.7 million, marking a year-over-year decrease of 16306.64%. This contributed to the annual value of $15.7 million for FY2024, which is 774.98% up from last year.
  • According to the latest figures from Q3 2025, Staar Surgical's Cash from Operations is $2.7 million, which was down 3011.01% from -$27.2 million recorded in Q2 2025.
  • Over the past 5 years, Staar Surgical's Cash from Operations peaked at $32.0 million during Q4 2023, and registered a low of -$27.2 million during Q2 2025.
  • Its 5-year average for Cash from Operations is $4.2 million, with a median of $3.4 million in 2022.
  • In the last 5 years, Staar Surgical's Cash from Operations crashed by 16813.48% in 2022 and then skyrocketed by 97639.73% in 2023.
  • Quarter analysis of 5 years shows Staar Surgical's Cash from Operations stood at $8.5 million in 2021, then crashed by 65.05% to $3.0 million in 2022, then surged by 976.4% to $32.0 million in 2023, then plummeted by 97.99% to $642000.0 in 2024, then surged by 315.42% to $2.7 million in 2025.
  • Its Cash from Operations was $2.7 million in Q3 2025, compared to -$27.2 million in Q2 2025 and -$5.7 million in Q1 2025.